Parkwood Institute

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease8 trials
• Frontotemporal dementia5 trials
• Lewy body dementia2 trials
• Stroke2 trials
• ALS (motor neurone disease)1 trial
• Cerebral palsy1 trial
• Depression1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Recruiting5 trials
• Enrolling by invitation3 trials
• Active, not recruiting2 trials
• Completed2 trials
• Terminated2 trials
• Not yet recruiting1 trial

Lead sponsor

• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's5 trials
• Alector Inc.2 trials
• University of Southern California2 trials
• AriBio Co., Ltd.1 trial
• McMaster University1 trial
• and 4 more

Running trials

• Enrolling by invitation

  BioMIND Biospecimen Repository

  NCT07912736· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

• Recruiting

  Cryoneurolysis for Spasticity Treatment: Long-term Clinical Outcomes and Mechanisms in the Central Nervous System

  NCT06958289· Sue Peters· Source

  Contact: Nagina Naz, BSc

• Recruiting

  Optimizing Recruitment to Drive Equitable Research Opportunity in Stroke Rehabilitation Trials in Canada

  NCT06576089· McMaster University· Source

  Contact: Shiela Geniblazo

• Not yet recruiting

  Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia

  NCT04405596· Phase 1/2· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

  Contact: Carolina Silveira, PhD

• Enrolling by invitation

  Biomarkers in a Candian Memory Clinic

  NCT06843109· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

• Recruiting

  Evaluation of the Transitional and Lifelong Care Program

  NCT05849285· Western University, Canada· Source

  Contact: Josh Wiener, MSc

• Recruiting

  Investigating Genetic Status in Patients Presenting to Clinic

  NCT05911932· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

  Contact: S Jesso, BA

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· University of Southern California· Source

• Active, not recruiting

  Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

  NCT05531526· Phase 3· AriBio Co., Ltd.· Source

• Active, not recruiting

  The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

  NCT04950868· Phase 1· Verinder Sharma· Source

• Recruiting

  Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias

  NCT02945774· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

  Contact: S Jesso, BA

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease4 recruiting
• Frontotemporal dementia3 recruiting
• Lewy body dementia2 recruiting
• Stroke2 recruiting
• Cerebral palsy1 recruiting

Closed trials

• Terminated

  Continuation Study for Latozinemab

  NCT06111014· Phase 3· Alector Inc.· Source

• Completed

  A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

  NCT04592874· Phase 2· Alector Inc.· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· University of Southern California· Source

• Terminated

  Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

  NCT02085265· Phase 2· Sunnybrook Health Sciences Centre· Source